Givaudan SA

GIVN

CH0010645932

Specialty Chemicals

Market Closed - Swiss Exchange Other stock markets 11:30:08 2024-07-17 EDT			5-day change	1st Jan Change
4,217 ^CHF	-1.79%		-2.72%	+21.04%

07-15	GIVAUDAN AG : Gets a Neutral rating from UBS	ZD
07-05	DZ Bank Initiates Coverage on Givaudan With Hold Recommendation	MT

GIVAUDAN AG : UBS reiterates its Sell rating

January 31, 2023 at 06:23 am

The analyst from UBS, Charles Eden, maintains his advice to sell. The target price remains set at CHF 2800.

Latest news about Givaudan SA

GIVAUDAN AG : Gets a Neutral rating from UBS	07-15	ZD
DZ Bank Initiates Coverage on Givaudan With Hold Recommendation	07-05	MT
DZ Bank Initiates Givaudan Coverage at Hold	07-05	MT
GIVAUDAN AG : DZ Bank reiterates its Neutral rating	07-04	ZD
GIVAUDAN AG : JP Morgan reiterates its Neutral rating	07-04	ZD
Swiss Market Index Blinks Red Amid Latest EU Inflation, Unemployment Data	07-02	MT
GIVAUDAN AG : JP Morgan sticks Neutral	07-02	ZD
Givaudan Completes Purchase of Italian Makeup, Skincare Group	07-02	MT
AlphaValue/Baader Europe Lowers Price Target on CIE Financiere Richemo	07-01	MT
New semester, new state of mind	07-01
GIVAUDAN AG : Goldman Sachs maintains a Buy rating	07-01	ZD
Givaudan SA acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a.	06-30	CI
BNP Paribas Exane Lowers Price Target on Swatch Group, Maintains Neutral Recommendation	06-28	MT
Would you like some more inflation?	06-28
GIVAUDAN AG : Baader Bank keeps a Sell rating	06-24	ZD
EU fines IFF for obstructing investigation of suspected fragrance cartel	06-24	RE
GIVAUDAN : Jefferies raises price target	06-20	CF
GIVAUDAN AG : Barclays reiterates its Neutral rating	06-20	ZD
GIVAUDAN AG : UBS reiterates its Neutral rating	06-20	ZD
GIVAUDAN AG : Berenberg reaffirms its Neutral rating	06-19	ZD
GIVAUDAN AG : Jefferies maintains a Sell rating	06-19	ZD
GIVAUDAN AG : JP Morgan remains Neutral	06-18	ZD
GIVAUDAN AG : Deutsche Bank reiterates its Neutral rating	06-14	ZD
Deutsche Bank Lifts Price Target on Givaudan, Maintains Hold Recommendation	06-11	MT
Dsm-firmenich sees boost as weight-loss drugs spur healthier choices	06-10	RE

Givaudan SA is one of the world's leading producers of flavors and perfumes. Net sales break down by family of products as follows: - flavors (52.1%): for producing salted side dishes prepared dishes, snacks, soups and sauces, meat and poultry), beverages (fruit juices, instant beverages), sweet goods, and dairy products; - perfumes (47.9%): intended to the production of cosmetic products and of consumer products (cleaning and maintenance products, etc.). At the end of 2023, the group had 78 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (1.2%), Europe (29%), Asia/Pacific (24.6%), North America (23.9%), Latin America (12.3%), Africa and Middle East (9%).

Sector

Specialty Chemicals

Calendar

2024-07-23 - Q2 2024 Earnings Release

Related indices

SMI , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Ratings for Givaudan SA

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4,217 CHF

Average target price

4,022 CHF

Spread / Average Target

-4.62%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
GIVAUDAN SA	+21.04%	44.25B
ECOLAB INC.	+22.67%	70.02B
SIKA AG	-4.09%	47.08B
FUJIFILM HOLDINGS CORPORATION	+35.82%	29.07B
EMS-CHEMIE HOLDING AG	+5.51%	18.91B
SYMRISE AG	+11.65%	17.15B
CELANESE CORPORATION	-6.12%	16.11B
POSCO FUTURE M CO., LTD.	-31.20%	14.28B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-32.02%	12.17B
NITTO DENKO CORPORATION	+27.68%	11.8B

Other Specialty Chemicals

Givaudan SA

Equities

GIVN

CH0010645932

Specialty Chemicals

GIVAUDAN AG : UBS reiterates its Sell rating

Latest news about Givaudan SA

Chart Givaudan SA

Company Profile

Income Statement Evolution

Ratings for Givaudan SA

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Specialty Chemicals